耐多药结核病的流行病学、控制与治疗 - Suppr

Suppr

超能文献

Epidemiology, control and treatment of multidrug-resistant tuberculosis.

作者信息

Chaulet P, Raviglione M, Bustreo F

机构信息

WHO, Global Tuberculosis Programme, Geneva, Switzerland.

出版信息

Drugs. 1996;52 Suppl 2:103-7; discussion 107-8. doi: 10.2165/00003495-199600522-00021.

DOI:10.2165/00003495-199600522-00021

PMID:8869846

Abstract

摘要

相似文献

Epidemiology, control and treatment of multidrug-resistant tuberculosis.耐多药结核病的流行病学、控制与治疗

Drugs. 1996;52 Suppl 2:103-7; discussion 107-8. doi: 10.2165/00003495-199600522-00021.

The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?多重耐药的威胁：结核病是否永远无法治疗或无法控制？

Lancet. 1999 Mar 20;353(9157):998-9. doi: 10.1016/S0140-6736(99)01439-7.

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment.耐多药结核病：流行病学、预防与治疗

Br Med Bull. 2005 Jun 14;73-74:17-24. doi: 10.1093/bmb/ldh047. Print 2005.

[Drug-resistant pulmonary tuberculosis at the penitentiaries].[监狱中的耐多药肺结核]

Probl Tuberk Bolezn Legk. 2008(12):60-3.

[Drug resistance of Mycobacteria tuberculosis in patients with new-onset pulmonary tuberculosis].新发肺结核患者中结核分枝杆菌的耐药性

Probl Tuberk Bolezn Legk. 2005(12):37-9.

[Isoniazid and rifampicin resistance and prior treatment for tuberculosis].[异烟肼和利福平耐药性以及结核病的既往治疗情况]

Cad Saude Publica. 2003 Sep-Oct;19(5):1277-81. doi: 10.1590/s0102-311x2003000500006. Epub 2003 Dec 2.

Shorter treatment duration for selected patients with multidrug-resistant tuberculosis.部分耐多药结核病患者的治疗疗程缩短

Eur Respir J. 2011 Jul;38(1):227-30. doi: 10.1183/09031936.00186310.

[Antitubercular chemotherapy].[抗结核化疗]

Rev Mal Respir. 1997 Dec;14 Suppl 5:S88-104.

Multiple drug resistant tuberculosis.多重耐药结核病

J Clin Pathol. 1997 Feb;50(2):89-90. doi: 10.1136/jcp.50.2.89.

Multidrug-resistant tuberculosis--can the tide be turned?耐多药结核病——局势能扭转吗？

Lancet Infect Dis. 2001 Oct;1(3):199-202. doi: 10.1016/s1473-3099(01)00096-2.

引用本文的文献

Fatal tuberculous meningitis caused by immune restoration disease.

J Neurol. 2004 Dec;251(12):1522-3. doi: 10.1007/s00415-004-0563-4.

本文引用的文献

Drug-resistant tuberculosis: review of the worldwide situation and the WHO/IUATLD Global Surveillance Project. International Union Against Tuberculosis and Lung Disease.耐药结核病：全球形势回顾与世卫组织/国际防痨和肺部疾病联盟全球监测项目。国际防痨和肺部疾病联盟。

Clin Infect Dis. 1997 Jan;24 Suppl 1:S121-30. doi: 10.1093/clinids/24.supplement_1.s121.

Surveillance of drug resistance for tuberculosis control: why and how?结核病控制中的耐药监测：为何及如何开展？

Tuber Lung Dis. 1995 Dec;76(6):487-92. doi: 10.1016/0962-8479(95)90523-5.

Multidrug-resistant tuberculosis and its control.耐多药结核病及其控制

Res Microbiol. 1993 Feb;144(2):104-10. doi: 10.1016/0923-2508(93)90023-u.

[Clinical trial of a combination of three drugs in fixed proportions in the treatment of tuberculosis. Groupe de Travail sur la Chimiothérapie de la Tuberculose].

Tuber Lung Dis. 1995 Oct;76(5):407-12. doi: 10.1016/0962-8479(95)90006-3.

[Possible causes of the failure of the treatment of pulmonary tuberculosis ; how to avoid them].[肺结核治疗失败的可能原因；如何避免这些原因]

Bull Int Union Tuberc. 1980 Sep-Dec;55(3-4):93-101.

A controlled clinical trial of daily and intermittent regimens of rifampicin plus ethambutol in the retreatment of patients with pulmonary tuberculosis in Hong Kong. A Hong Kong Tuberculosis Treatment Services/Brompton Hospital/British Medical Research Council investigation.香港利福平加乙胺丁醇每日及间歇用药方案治疗肺结核复治患者的对照临床试验。香港结核病防治服务处/布朗普顿医院/英国医学研究委员会的一项调查。

Tubercle. 1974 Mar;55(1):1-27. doi: 10.1016/0041-3879(74)90064-6.

[Controlled study comparing 3 daily chemotherapy regimens for six months in pulmonary tuberculosis in routine practice in Algiers. Results at 30 months].[在阿尔及尔的常规实践中，比较三种每日化疗方案治疗肺结核六个月的对照研究。30个月时的结果]

Rev Mal Respir. 1985;2(4):209-14.

[Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].[在阿尔及利亚撒哈拉地区比较6个月疗程与12个月疗程治疗肺结核的治疗试验结果。最终报告：治疗开始3年后的结果]

Rev Mal Respir. 1986;3(2):73-85.

Five-year follow-up of a clinical trial of three 6-month regimens of chemotherapy given intermittently in the continuation phase in the treatment of pulmonary tuberculosis. Singapore Tuberculosis Service/British Medical Research Council.一项关于肺结核治疗中继续期采用三种6个月间歇化疗方案的临床试验的五年随访。新加坡结核病防治所/英国医学研究委员会

Am Rev Respir Dis. 1988 May;137(5):1147-50. doi: 10.1164/ajrccm/137.5.1147.

Human bioavailability studies.人体生物利用度研究。

Bull Int Union Tuberc Lung Dis. 1989 Mar;64(1):38-40; 40-2 discussion.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验